概念词典 · 方法论
隐形冠军
在产业链某个细分环节占据绝对统治地位、但行业外几乎无人知晓的小公司——Serenity 整套研究方法的核心目标。
别名： 隐形冠军／ hidden champion／ 卡点／ 上游卡点／ chokepoint
是什么
“隐形冠军” 这个词源自德国管理学者 Hermann Simon 对德国中小企业的研究。Serenity 借用它来描述他寻找投资标的的核心目标：
在 AI 算力扩张这条产业链上，哪一个细分环节产能跟不上，而做这环节的公司又恰好小到没被大基金覆盖——这就是值得重仓的隐形冠军。
三个判断维度
他在多条推文里阐述过他的筛选框架：
1. BOM 占比
拆开终端产品的物料清单 (Bill of Materials)，看这个公司的零件在总成本里占多大比例。比例越高、可替代性越低 → 定价权越强。
“$VPG 很可能在特斯拉 Optimus 的 BOM 占据极高份额”
2. 产能弹性差
“短缺时无法快速扩产”是隐形冠军的护城河。精密齿轮、化合物半导体衬底、特种激光器晶圆——这些环节扩产周期 18-36 个月。
3. 客户集中但不被替代
看似风险（客户高度集中）实际是壁垒：一旦被设计进客户的 BOM 就很难被换掉，因为重新认证成本高。
与”卡点 / chokepoint”的关系
“卡点”是 Serenity 自创的更口语化表达，含义和”隐形冠军”几乎一致。本站站名 「上游卡点」 也来自这个概念。
顺着供应链向上游走，找到那个没人盯着的卡点。
典型隐形冠军案例
| 公司 | 卡的什么 |
|---|---|
| $AXTI | InP 衬底（全球前三） |
| $SIVE | DFB/CW 激光器（CPO 必备） |
| $VPG | 应变片（人形机器人感知层） |
| 绿的谐波 | 谐波减速器（机器人关节） |
| IntelliEPI | InP 外延（衬底下游一环） |
反例：不是隐形冠军
他常用 “Fake it Until you make it” 标记一类自称隐形冠军但财务证据不足的公司：
- $POET：宣传 CPO 但实际产品和营收脱节
- $IREN：宣传 AI 数据中心但实质仍是矿机
提到此概念的推文 (111)
按时间倒序 · 滚到底自动加载更多
-
LITE财报证实CPO 27H2放量，CW激光供需失衡且中国厂商落后。
$LITE 财报电话会要点： - “我们对共封装光学(CPO)规模化部署的时间表可见度已提高。我们确信，2027年下半年我们的超高功率激光芯片需求将强劲增长。” Lumentum 确认其领先客户将于 2027 年下半年启动 CPO 规模化放量。 - “我们最近获得了首个外部光源(ELS)模块订单，将于 2027 年下半年交付。” ELS 行业放量时间表。 - “非平面光学(NPO)机会对我们完全是增量，显著增加了光学市场的总规模(TAM)。” 激光瓶颈俱乐部的 TAM 进一步扩大。 - “我们预计 1.6T 光模块的采用将从财年第一季度开始加速，并持续至 2027 年。” - “即使在连续波(CW)激光领域，我们对自己提价的能力也感到惊讶。” $SIVE 及其他 CW 激光玩家拥有积极的定价权。 - “因此，我们能够获得可观的价格溢价，并预计这种溢价将维持下去，即使这些中国厂商上线。我也提醒人们，我认为一些中国激光供应商目前并未在市场上实际交付，所以当它们抛出那些大数字时，没有追索权。迄今为止，我们在其产出方面尚未看到类似情况。” 中国厂商在激光/产能方面落后于市场预期，得到 $AAOI 和 $LITE 的证实。 - “不幸的是，我们在高功率激光的发货上远远落后。” “需求信号增加，相对于我们的供应能力，我们更加落后。” 超高功率(UHP) CW 激光产能存在极端供需失衡，EML 需求持续失衡。年底发货约 +5000 万美元 -> 1 亿美元+（“三位数季度”），进入 2027 年下半年和 2028 年更大的规模化需求。 - “所以，我认为过去三个月我们真正试图做的是确保更多的衬底供应”（因为供需失衡），“我们从 $AXTI 找到了额外的衬底帮助。他们是伟大的合作伙伴。” 磷化铟(InP)衬底瓶颈出现。 要点总结： - Lumentum 确认 CPO 2027 年下半年放量，驳斥任何“延迟”新闻为市场“噪音”。（一份延迟报告造成了巨大损害，Nvidia、Lumentum 等公司花了数周进行危机公关）。 - CW 激光需求在 2027 年下半年放量。 - 超高功率 CW 激光产能的极端供需失衡让 Lumentum 感到惊讶。 - 超高功率激光拥有极高利润率，并能对 CW 激光产能提价。 - 中国在激光/产能方面进一步落后。 基本上验证了西方 CW 激光玩家的时间表 + 需求/定价。 在主要放量开始之前，CW 激光的稀缺性已经发生……
英文原文
$LITE earnings transcript TLDRs: - "Our visibility into the timing of CPO scale-up deployments has also sharpened. We remain confident in a demand ramp for our ultra-high-power laser chips in the second half of calendar 2027" H2 2027 start of CPO scale up ramp confirmed from Lumentum for their lead customer. - "We were recently given our first external light source, or ELS, module purchase for delivery by the second half of calendar 2027" ELS industry ramp timelines - "The NPO opportunity is completely additive for us, significantly increasing the optical TAM." More TAM for laser chokepoint club - "we expect the 1.6T transceiver uptake to intensify starting in fiscal Q1 and sustain through calendar 2027." - "Even in CW, we’ve been surprised at our ability to price up" Positive pricing power for $SIVE and the other CW laser players. - "As a result, we are able to command a nice price premium that we expect to sustain, as these Chinese if these Chinese guys come online. I caution people also, I think people are some of these Chinese laser suppliers are not delivering in the market today, so they have there is no recourse when they throw out these big numbers. We have not seen anything like that to date in terms of their output." Chinese players are more behind than markets expect, corroborated by $AAOI and $LITE. - "We are way behind in our shipments, unfortunately, on high-powered lasers" "The demand signal has increased, and we are very much further behind relative to our ability to supply." Extreme demand imbalance for UHP CW laser capacity, continued demand imbalance for EML. Shipping roughly +$50M year end -> $100m+ ("triple digit quarter") into much larger H2 2027 and 2028 scale up demand,. - "So what we are trying to do, I think, really in the last three months is secure even more substrate supply" (because of demand imbalance), "we found additional substrate help from $AXTI They are a great partner." Hello InP substrate bottleneck. TLDR: - Lumentum CPO scale up H2 2027 shipments got confirmed, dismissed any "delay" news as market "noise". (one delay report caused so much damage, and it took Nvidia, Lumentum, and all these companies weeks to do damage control). - CW lasers demand ramp second half of 2027 - Extreme demand imbalance for UHP CW laser capacity surprised Lumentum - UHP lasers commands very high margins and is able to price up CW laser capacity. - China further behind in the laser/capacity angle. Basically just validated timelines + demand/pricing for Western CW laser players. CW laser scarcity is already happening before the main volume ramp even begins...
-
SIVE撤回收购案，从激光瓶颈扩大TAM，博主预期更高。
@softmaxedx 这只是激光阵列产能建模。看多逻辑是 $SIVE 撤回其 Cloud Light 收购案，并从激光瓶颈处扩大总可寻址市场(TAM)。我个人预期更高，但大家可以自行估值。
英文原文
@softmaxedx This is just laser array capacity modeling. The bull case is $SIVE pulling their own Cloud Light acquisition and multiplying TAM starting from the laser chokepoint. I have much higher expectations personally, but people can make their own valuation estimates. https://t.co/sS372W0SYR
-
AAOI财报揭示CPO激光器产能瓶颈，利好少数西方厂商，中国技术落后数年。
哇，$AAOI 的财报中对于 $SIVE 及其他激光器玩家来说，利好一个接一个。 1. $AAOI 并未实质性参与第一代共封装光学(CPO)部署。 “我们根本无法生产足够的[CPO激光器]来参与他们当前的一代[CPO]部署，因为产能根本不够。我们必须优先保障自有光模块的激光器供应。” 因此，第一代CPO激光器的部署范围可能会进一步缩小，仅限于$SIVE、$LITE、$AVGO和$COHR等西方厂商。 如果$AAOI不得不拒绝更多客户，独立的CPO连续波(CW)激光器产能将变得更有价值。 还要记得Trendforce曾提到$AMD签署了CW长期协议(LTA)？$COHR/$LITE已与$NVDA签署了产能协议…… 我原以为是$AAOI，但他们可能出局了。$MTSI在早期CPO参与中也不显眼（除了NPO外财报未提及，且从Ayar网站移除）。 所以我在想$AMD在Helios项目中会与谁合作（例如Sivers+Ayar现在更可能是候选者）？ 顺便说一句，这对$AAOI并非看空，因为他们光模块业务需求旺盛。只是对少数有产能的合格CPO激光器厂商更加看多。 2. 磷化铟(InP)激光器/光模块的需求失衡与瓶颈。 AOI CEO的话某种程度上证实了这一点：“客户需求比扩建后的产能高出20%-40%。” “我们几乎每周都从几家大客户那里收到这种需求。激光器目前是光模块业务最大的瓶颈。” 3. 中国在CPO波分复用(DWDM)规格激光器方面落后数年。 我之前在渠道调研CPO竞争时曾覆盖过这一点。 但$AAOI确认中国“至少落后两三年甚至更久”才能拥有CPO激光器，这极大地印证了西方激光器在CPO激光器卡脖子环节上的防御性地位。 总结： - CW激光器和光模块需求严重失衡。 - $AAOI因产能限制未进入第一代CPO（对$AAOI不算看空，因其光模块需求旺盛，但对$SIVE等少数有产能的独立厂商更是利好）。 - 中国在CPO激光器方面落后数年。
英文原文
Wow, there's gem after gem in $AAOI earnings for $SIVE + other laser player readthrough. 1. AAOI not meaningfully participating in CPO first-gen deployments. "We just can’t make enough of them [CPO lasers] to be involved in their current first-generation [CPO] deployments because there’s just not enough capacity. We have to prioritize our ability to make lasers for our own transceivers first" So first-gen CPO laser deployments, might even be narrowed down further for Western players like $SIVE, $LITE, $AVGO, and $COHR. And independent CPO CW laser capacity became more valuable if $AAOI had to turn away more customers... Also remember Trendforce was talking about $AMD singing CW LTAs? $COHR / $LITE have capacity signed with $NVDA ... I thought it would be $AAOI, but they might be out of the equation. $MTSI also doesn't look meaningful with early CPO participation (eg. no mention in ER aside from NPO, and removal from Ayar website). So I wonder who players like $AMD is going to go with for Helios (eg. Sivers + Ayar more likely candidate now)? Btw, this is not bearish AAOI because they have too much demand for optical transceiver business. Just more bullish on the existing few qualified CPO laser names that have capacity. 2. Demand imbalance and bottleneck for InP lasers / optical transceivers. AOI's CEO stated kinda supported that when they said: "The customer demand is 20%-40% higher" than expanded built out capacity. "We are getting this kind of demand from several big customers almost every week. Lasers are the biggest bottleneck right now for the transceiver business" 3. China being years away from having CPO DWDM specification lasers. I covered this earlier when looking at CPO competition from channel checks. But AAOI confirming that China is "easily at least two, three years or even longer from having CPO lasers is incredible tread through on defensibility Western laser positioning in the CPO laser chokepoint. TLDR: - High demand imbalance for CW lasers and optical transceivers. - $AAOI not in first-gen CPO due to capacity constraints (not exactly bearish AAOI because they have too much demand for their optical transciver business, but even better news for the few independent players with capacity coming online like $SIVE) - China years behind in CPO lasers.
-
AI激光器供应危机加剧，验证AAOI等标的瓶颈逻辑。
$LITE CEO Michael Hurlston 在 RAISE 峰会上警告称，AI 数据中心（AI DCs）用磷化铟(InP)激光器的供应缺口： 正面临比存储芯片更严重的供应链危机。 凭借 Lumentum 的 5 座 InP 晶圆厂，其出货量将比客户需求低 30% 以上。 这在目前的电吸收调制激光器(EMLs)上尤为明显，但随着共封装光学(CPO)的推进，已扩展至连续波(CW)激光器。 我一直看好 $AAOI、$SIVE、$LITE 和 $COHR 带来的激光器卡脖子+瓶颈逻辑。很高兴这一论点开始得到验证。
英文原文
$LITE CEO Michael Hurlston at the RAISE Summit warned that the supply gap for InP lasers for AI DCs: Is facing a more severe supply chain crisis than memory. And with Lumentum's 5 InP fabs, shipments would be more than 30%+ below customer demand. This is especially visible with EMLs today but is already expanding to CW, especially as CPO ramps. I've always been a fan of the laser chokepoint + bottleneck from $AAOI, $SIVE, $LITE, and $COHR. And glad this thesis is starting to see validation.
-
博主澄清CPO延迟谣言，认为亚洲股错杀，看好MSSCorp及早期受益股。
@Erick_P23 核心逻辑更偏向于共封装光学(CPO)的规模化，预计其复杂性将使MSSCorp成为检测良率方面的垄断型瓶颈（他们声称目标市场份额为90%）。尽管这些技术也可用于其他领域。 $FORM 的产能爬坡早了很多，所以下次财报中营收可能会开始显现？ 无论如何，亚洲概念股因CPO时间表延迟的报道而大幅抛售，但我通过$AMD 大会上的渠道核实发现该报道不实。 我认为我的观点没有改变，更多的是在等待2027年。 像Shunsin这样拥有更多确认的规模化交换机出货量，以及像 $AAOI / $SIVE 这样的激光概念股，其产能爬坡要早得多。在我看来，这只是时间线的问题，以及市场何时愿意对此进行定价。
英文原文
@Erick_P23 Thesis is more for CPO scale up expecting complexity making make MSSCorp a monopoly-type chokepoint over inspection yields (they were claiming 90% market share target). Although they can be used for other segments. $FORM ramped a lot earlier, so maybe will revenue would start to appear in next earnings? Regardless, Asian names sold off extremely hard on CPO timeline delay report that I found to be incorrect with my channel checks at the $AMD conference. Don't think my views have changed, it's moreso waiting for 2027. Names with more confirmed scale-out switch volumes like Shunsin + laser names like $AAOI / $SIVE ramp a lot earlier. It's just timelines in my view and when markets want to price that in.
-
类比LITE历史涨幅，看好SIVE凭借CPO技术主导新瓶颈环节。
@CArgyres29810 我认为人们往往忘记，$LITE 凭借对电吸收调制器(EML)瓶颈环节的控制，在两年内估值从 30 亿美元飙升至 600 亿美元以上。这发生在高盛预测到 2028 年下半年总可寻址市场(TAM)将 9 倍扩张至约 1540 亿美元之前。$SIVE 有机会凭借 1.6T 和共封装光学(CPO)技术主导下一个连续波(CW)瓶颈环节。而它目前的市值仅为约 11 亿美元。
英文原文
@CArgyres29810 I think people tend to forget that $LITE went from a $3B valuation to $60B+ in 2 years time from owning the EML chokepoint. This was before the 9x TAM expansion to ~$154B per GS by H2 2028. $SIVE has the opportunity to dominate the next CW chokepoint with 1.6T and CPO. And it's sitting at ~$1.1B now.
-
NVDA导致EML瓶颈迫使架构转向，IMO光子学及CW激光器成关键瓶颈。
集成模块光学(IMO)光子学主题+连续波(CW)激光器瓶颈是顶级的。市场真的像有短期记忆丧失症，忘了$LITE从2024年到现在是如何从30亿美元涨到650多亿美元的。因为$NVDA导致了外延激光管芯(EML)瓶颈，并迫使架构改变。我们实际上正在看到同样的情况
英文原文
IMO photonics theme + CW laser chokepoint is goated. It's legit like markets have short term memory loss and forgot how $LITE went from $3B -> $65B+ from 2024 to now. Because $NVDA caused EML bottlenecks, and forced architectural changes. We're literally seeing the same
-
LPK 玻璃基板设备具垄断优势，预计量产爬坡后市值可达 30-50 亿。
关于 $LPK：如果让我猜，当它们全面量产爬坡时，市值达到 30 亿至 50 亿美元似乎是合理的。 对我来说，这感觉更具非对称性，因为这只是一个等待游戏，而且它们已经拥有玻璃基板的客户。 小型设备供应商的瓶颈通常受限于总可寻址市场 (TAM)，除非你是 ASML 或像 KLAC 那样拥有多个瓶颈，否则很难达到 200 亿美元以上。 在全面量产爬坡前夕，很少有像这样占主导地位的“垄断者”： 也许你有类似： - Aixtron (MOCVD) ~80 亿美元 - Towa (压缩键合) ~20 亿美元 - Techwing (内存处理器/立方探针) ~15 亿美元 - MSScorps (CPO 检测)，但处于量产前阶段。8.5 亿美元 - Riber (量子分子束外延)，非常早期的量产前阶段 ~3.5 亿美元 然后是 LPK 激光用于玻璃核心基板（即将量产），市值约 7.3 亿美元，从主题上讲应该比内存享有更多溢价。（例如，主要先进封装转变，CPO 相关等）。 我知道很多晦涩的化学垄断者，但由于其物料清单 (BOM) 远低于设备，因此没有受到太多关注。 但对于 LPK 你有： 例如：“全球主要玩家中 80% 的客户选择了 LPKF 设备”。 在玻璃核心量产中，LIDE 市场份额目标为 70%，应该非常重要。（披露：持有，上述列出的名称中除了 Techwing/Aixtron 外，NFI）。 这只是如果你跟随 $AEHR 在约 35 亿美元时的路径： - <5 亿美元：“哦，他们没有客户！” --->（可能在这里的中间某处）。 - <15 亿美元：“也许很快就会有量！” - 30 亿美元及以上：“看起来他们开始全面量产爬坡了。” 这只是我个人经验中关于瓶颈设备供应商周期的一课。
英文原文
As for $LPK: Maybe $3B-$5B seems reasonable when they fully volume ramp if I had to guess. Feels more asymmetrical to me personally since it's just a waiting game and they have the customers for glass substrates. Small machine supplier chokepoints usually cap out from TAM though and don't go to $20B+ unless you're ASML or hold many chokepoints like KLAC. Not many dominant "monopolies" like these out there right before volume ramp this small: Maybe you have stuff like: - Aixtron (MOCVD) ~$8B - Towa (compression bonding) ~$2B - Techwing (memory handler/cube probes) ~$1.5B - MSScorps (CPO inspection), but pre-ramp. $850M - Riber (quantum MBE), very pre-ramp ~$350M Then LPK Laser for glass core substrates (about to ramp) at ~$730M, which thematically should have more premiums than memory. (eg. major advanced packaging shift, CPO adjacent, etc). Lot of obscure chemical monopolies I know of, but those don't get as much attention cause BOM is much lower than equipment. But for lpk you have: eg. “80% of customers among major global players have selected LPKF equipment”. 70% of LIDE market share target for TGV in the glass-core ramp, should be very material. (disclosure: own, the listed names above aside from techwing/aixtron, NFI). Just kinda the path they go if you follow $AEHR at ~$3.5B now: - <$500m: "Oh they have no customers!" ---> (probably somewhere in the middle here). - < $1.5B: "Maybe volume comes soon!" - $3B+ onward: "Looks like they're starting to volume ramp. Just a lesson for the cycle of the chokepoint machine suppliers from my personal experiences.
-
澄清误解，论证SIVE在CPO及可插拔光模块中的核心地位，强烈看多。
这是一个误解： $SIVE 是下一代架构的激光器供应商，不仅仅局限于共封装光学(CPO)的规模扩展(scale up)。 可插拔(Pluggable)、规模扩展(scale out) CPO、规模扩展(scale up) CPO、近封装光学(NPO)等。 - Sivers 和 $JBL 开启了“神模式”，开发了采用连续波(CW)激光器的 1.6T 光模块。 有效地绕过了电吸收调制激光器(EML)的瓶颈，甚至提高了能效。 根据捷普(Jabil)管理层的说法，他们建立了“相对显著的护城河”。 因此，对于下一代 1.6T 可插拔光模块，Sivers 似乎立即被采用。 市场也错过了这一细微差别：在捷普宣布后，其他可插拔厂商也主动联系，SIVE 现在正与他们合作（可能处于联合开发、资格认证阶段）。 像 Lumentum 这样垂直整合的光模块厂商并不多（想想中际旭创/新易盛，可能还有其他）。 所以这些是正在进行的开发，只是尚未公开披露，随时可能发布新的新闻稿。 - 对于 2026 年下半年开始的 CPO 规模扩展(scale out)，如 $POET，$SIVE 是这些厂商的激光器供应商。 - 规模扩展(scale up) CPO 将在 2027 年下半年到来，来自 Ayar 和英伟达(Nvidia)的 NVLink CPO 生态系统，这是光模块厂商的主要放量阶段。 但在这里，$SIVE 看起来在供应链映射中碾压其他所有玩家。 因为他们很可能早在规模尚小时就与 $MRVL Celestial、Lightmatter、Lightelligence 等合作并完成了设计导入。 除此之外还有： 对于像 $GFS 这样的晶圆代工厂，$SIVE 是参考激光器。 甚至不包括像 O-Net 这样与 $SIVE 合作构建 ELS 的大公司，可能用于亚洲超大规模数据中心的供应链。 这就是为什么 $SIVE 是我目前最看好的激光器瓶颈长持标的。 感觉从 2027 年初开始，他们在新的光学架构中无处不在。
英文原文
That’s a misconception: $SIVE is the laser supplier for next gen architectures, not just CPO scale up. Pluggable, scale out CPO, scale up CPO, NPO, etc. - Sivers and $JBL went god-mode and developed 1.6T optical transceivers with CW lasers. Effectively designing around the EML bottlenecks, and even made things more power efficient. From quotes from Jabil management they created a “relatively dramatic moat”. So for the next gen of 1.6T pluggable transceivers, Sivers seems immediately used. Markets missed this nuance too: after Jabil’s announcement, other pluggable players reached out, and SIVE is working with them now (prob codevelopment, qualification stage). There’s not too many players that build optical transceivers that aren’t vertically integrated like Lumentum (think: Innolight/eoptolink, and maybe others). So these are active developments, just not public material yet and could be a new press release anytime. - for CPO scale out which happens H2 2026 onward like $POET , $SIVE is a laser supplier for those players. - scale up CPO is h2 2027, from Ayar and Nvidia’a NVLink CPO ecosystem and that’s the main volume ramp across optical players. But this is where $SIVE looks like they mog every other player from supply chain mapping. Since they’ve likely been working + designed in with $MRVL Celestial, Lightmatter, Lightelligence and the others since they were small way back when. On top of things like this: For foundries like $GFS , $SIVE is the reference laser. Not even including massive companies like O-Net building ELS with $SIVE, likely for the Asian hyperscalers supply chains. This is why $SIVE is by far my favorite laser chokepoint long. Feels like they’re everywhere in new optical architectures starting beginning of 2027.
-
回顾核心欧洲多头持仓，重点解析Sivers在光子学领域的瓶颈地位。
简单回顾一下，以下是我所有的核心欧洲多头持仓： 1. $SIVE 2. $LPK 3. $SOI 4. $RPI 5. $IQE 6. $ALRIB 7. $XFAB Sivers：如你所知，它是下一代光子学的核心激光瓶颈环节，涵盖从1.6T可插拔光模块到共封装光学(CPO)。 嵌入在许多超大规模云计算服务商的供应商（如Jabil）中。
英文原文
Just as a recap, these were all my core European longs: 1. $SIVE 2. $LPK 3. $SOI 4. $RPI 5. $IQE 6. $ALRIB 7. $XFAB Sivers: As you know by now, core laser chokepoint over next generation photonics, from 1.6T pluggables to CPO. Embedded in many hyperscaler suppliers from Jabil
-
认为SIVE可能是明年CPO的关键瓶颈。
$SIVE 看起来像是明年 CPO 的关键 chokepoint 和 bottleneck。 我不断看到非技术人士发布的信息漏掉了所有细节。 原因如下： 1. $LITE 财报已经发出信号，CW 激光器存在瓶颈。 激光器晶圆厂产能大量分配给 EML……
英文原文
$SIVE looks like both a chokepoint and a bottleneck for CPO next year. Keep seeing information published from nontechnical people who miss any nuances. Here’s the reason why: 1. CW lasers are bottlenecked signaled by $LITE earnings. Laser fabs are heavily allocated to EML
-
称SIVE是最近最明显、仍在重估的CPO激光瓶颈。
回复 @_king142：$SIVE 可能是最近最明显、仍在重估中的激光器瓶颈，因为它似乎出现在每个 $NVDA NVLink CPO 生态伙伴以及 merchant/ASIC CPO 供应链里。 也许下一个是 CPO 中的无源光组件供应链。
英文原文
@_king142 $SIVE was probably the most recent visible laser chokepoint that’s still being rerated since seem to be in every $NVDA NVLink CPO ecosystem partner + merchant/asic cpo supply chains. Maybe passive optical components supply chains in CPO next.
-
暗示某光子学公司成为NVDA NVLink Fusion CPO生态上游激光瓶颈。
哇……今天发布了一个极具转折意义的新消息。 这让某家光子学公司成为： $NVDA NVLink Fusion CPO 生态的事实上的上游激光瓶颈。 它们的激光器现在进入了 Nvidia 的光基础设施供应链。 有人能猜到名字吗？
英文原文
Wow… new extremely transformative news got released today. Making a certain photonics company: The effective upstream laser chokepoint for $NVDA NVLink fusion CPO ecosystem. With their lasers now in Nvidia’s optical infrastructure supply chains. Can anyone guess the name?
-
SIVE作为光子学激光瓶颈，获GFS/JBL等公开验证。
-> IP 收购 -> 只是等待 CPO 起飞 $SIVE 是光子学的激光瓶颈，并已被公开验证： - $GFS（根据演示，是 CPO 两家公开激光供应商之一，另一家是 $LITE） - $JBL（与 Sivers 构建的可插拔产品拥有“相当显著的护城河”） -
英文原文
-> IP acquisition -> Just waiting for CPO to take off $SIVE is a laser chokepoint for photonics and are publicly validated by: - $GFS (1 of 2 public laser suppliers with $LITE for CPO per presentation) - $JBL (“Relatively dramatic moat” for pluggables built with Sivers) -
-
称自己的瓶颈投资理论可能被历史研究，涉及AXTI/SOI/SIVE。
我在想，我的瓶颈投资理论…… 从 $AXTI 到 $SOI 再到 $SIVE，将来会不会被写进历史书研究？ 无论如何，我认为这里的每个人都是创造历史的一部分。 因为从路透社到机构再到各国，都在对 Serenity 引发的供应链博弈论作出反应。
英文原文
I wonder if my chokepoint investment theory… With $AXTI to $SOI to $SIVE will be studied in future history books? Regardless, I think everyone here is a part of making history. Given Reuters to Institutions to Countries are reacting to supply chain game theory with Serenity.
-
长文重申SIVE是最有吸引力的CPO/光子学敞口，并列出客户、资金、上市和M&A催化。
$SIVE 是我眼中最有吸引力的 CPO/光子学敞口。 针对错误信息：我没有卖出，也不打算卖出一股。 我确实认为它有一天会从约21亿美元成长为下一个800亿美元以上的 $LITE。 我个人也计划获得更多所有权，并支持它们的并购前景。 我相信财报电话会记录会非常正面。 过去几个月我们发现了很多线索：AlChip/Amazon 私募对 Ayar 有利，并暗示 $SIVE 进入 Trainium 4 设计；Wiwynn + Ayar 的 CPO 放量；$JBL 1.6T 光收发器与 Sivers 的放量比市场预期更快；O-Net 正在扩大与 $SIVE 的 ELS 努力；$YSS 收购 $SIVE 的 allspace 主要合作伙伴并把 Sivers 设计进太空防务主承包商；新的 CHIPS Act 资金；$POET 下半年放量及其新订单（$SIVE 作为光源）；关于 $AAPL 使用 $SIVE 激光用于下一代消费设备的信息；与 Lightelligence、Lightmatter、Celestial/$MRVL、Lightium、$AMD/$GFS、Ayar、可插拔 TAM、NASDAQ 上市、MSCI/Nasdaq OMX 纳入、M&A、$NOK 客户线索、$LITE 的 CW 瓶颈和 Win 产能协议等信息。 这些市场研究都发生在财报之前。任何财报结果只是对供应链映射的确认。 我不认为有人关心前一季度收入，因为 $SIVE 是一个极具吸引力的2027年多头，尤其是下半年以后。 我只看几件事：整体光子学超级周期的 TAM 扩张（如光引擎、ELS、可插拔），来自并购或业务发展的机会；现有客户的放量预期；NASDAQ 上市时间线，以获得更多流动性支持并购；以及 CPO/可插拔的新客户信号。
英文原文
$SIVE is the most compelling CPO/photonics exposure to me. Addressing the disinformation: I haven’t sold and don’t plan to sell a single share. I do think this ends up the next $80B+ $LITE one day from ~$2.1B. And I personally have plans to acquire more ownership + support their M&A prospects. I believe earnings transcripts will be strongly positive. As in the part few months we’ve discovered: > AlChip/Amazon private placements, which is positive for Ayar -> $SIVE implying Trainium 4 design in > Wiwynn + Ayar CPO scale up > $JBL 1.6T optical transceiver ramp with Sivers incoming faster than markets expected (with relatively dramatic moat + demand as much as they can produce) > O-Net scaling up ELS efforts with $SIVE > $YSS acquisition of $SIVE allspace lead partner, designing Sivers into Space defense primes > New CHIPS ACT funding for $SIVE > $POET H2 volume ramp and their new $50m -> $500m order (with $SIVE as light source) > information discovery around $AAPL using $SIVE lasers for next gen consumer devices > information discovery around links to Lightelligence (went public $10B+ MC) + Lightmatter as likely customers. > Celestial volume ramp with $MRVL indicators. > new customers working on TFLN with $SIVE like Lightium > $AMD going with $GFS for CPO, and GFS listing sivers as one of two laser suppliers > Ayar removing $MTSI / $LITE from their website and signaling $SIVE as primary source/sole source > Ayar raising $500m for volume ramp (intel, Mediatek, Nvidia, amd etc) > pluggable TAM expansion signaled from 2025 annual report > Nasdaq listing expected soon > MSCI small cap index / Nasdaq omx inclusion, making Blackrock, Vanguard and others passive buyers > M&A signaled from 2025 annual report + 2 new board members that have experience in that area > $NOK as likely customer from 2025 annual report. > $LITE getting cw bottlenecked from EML contracts, $SIVE signaling capacity agreements in place with Win, making the a likely bottleneck owner + chokepoint in CPO sector. All of this market research was done before earnings. Any results is just confirmation of supply chain mapping done. I don’t think anyone cares about former quarter revenue since $SIVE is an exceptionally compelling 2027 long, especially H2 onward. Only thing I’m looking at are: > TAM expansion of the overall photonics supercycle (eg. optical engine, ELS, pluggables) either from M&A or developments > volume ramp expectations from existing companies > Nasdaq listing timelines for more liquidity to support their M&A efforts > any new customers signaled for CPO/Pluggables
-
用私有CPO玩家估值论证SIVE作为上游激光瓶颈应获得更高估值。
给试图做 $SIVE 估值分析的人： Ayar、Celestial、Lightmatter、Lightelligence 今天大概估值约40亿到150亿美元以上。 Sivers 市值约26亿美元，而且很可能是它们所有人的上游激光供应商。 我甚至还没把 Poet、TFLN 相关的 Hyperlight/Lightium，或 Jabil 和其他未披露可插拔玩家纳入估值分析。 也没包括 CHIPS Act 合同、Apple/Nokia 关系，或 Aeva 等人形/物理 AI 业务。 散户对私募市场不太熟悉……但这些公司都被视为前沿 CPO 玩家，并且估值和规模都在迅速增长。 所以我预计 $SIVE 应该获得类似甚至更高估值，因为它有激光瓶颈溢价。尤其是在它通过并购扩展 TAM 和收入之后。 下个月 BlackRock/Vanguard/MSCI/NASDAQ 新资金流入会随时间缩小差距。 但 NASDAQ 上市可能才是真正给 Sivers 溢价的因素。
英文原文
For people trying to do valuation analysis on $SIVE. Ayar, Celestial, Lightmatter, Lightelligence are probably valued probably ~$4B-15B+ today. Sivers is ~$2.6B MC and they're likely upstream laser for them all. I'm not even including Poet, TFLN links like Hyperlight/Lightium, or pluggables like Jabil + other undisclosed players in valuation analysis. Or their other segments like CHIPS Act contracts or Apple/Nokia relationships. Or humanoid/physical AI segments with Aeva + others. Retail aren't as familiar with private markets... But these companies are all considered the frontier CPO players, and are growing valuations/scaling rapidly. So, I'd expect $SIVE to command similar if not higher valuations given laser chokepoint premiums. Especially after they pull off M&A to TAM expand revenue. New Blackrock/Vanguard/MSCI/NASDAQ inflow next month helps close that gap over time. But NASDAQ listing is probably what gives Sivers a premium.
-
Sivers为CPO玩家制造架构独特的DFB激光器，是咽喉要道且具高定价权。
光子学是复杂微妙的，用ChatGPT/Gemini会让你忽略其中所有的细微差别： 1. $SIVE实际上是一个咽喉要道，部分也是一个瓶颈。 它之所以是咽喉要道，是因为领先的CPO/光学超大规模玩家都要经过Sivers，很可能是：Ayar、Celestial、Lightmatter、Lightelligence、Poet。 如果你去掉Sivers，你实际上无法制造他们的一些产品，并使路线图延迟数年。 尽管许多是单一/主要来源，但正在朝着多来源方向发展。 至于瓶颈论点：Win Semi是扩大激光生产的瓶颈。 但是……微妙之处在于，当你拥有未来几年的产能分配时，如果玩家们争夺成品激光器的分配，你本身就成为瓶颈的一部分。 这就是人们错过的关于产能分配动态的微妙之处。 这就像说当Kioxia生产全部NAND时，$SNDK不是NAND瓶颈一样。 但当Sandisk拥有最终产出供应控制权时，他们就成为瓶颈+拥有所有定价权。 Sivers在分配的前提下控制CW激光器的产出供应，正如$LITE财报所示，CW激光器目前是瓶颈的，因为每个人似乎都在努力生产EML。 2. 就像大语言模型总是使用破折号一样。 你能看出人们什么时候用AI——当他们总是使用同样的「CW是一个愚蠢的可互换激光器」论点，或者在混淆不同架构后比较「功率」规格时。 这就是为什么你的「分析师」使用AI会一次又一次地犯错。 有CW激光器……然后有Sivers用DFB激光器实现的特定架构设计。 如果你比较$LITE与Sivers的功率规格，孤立来看Lumentum赢了。但它们是完全不同的激光架构。 所有领先的CPO玩家如Ayar，选择$SIVE是因为其高功率、低热、激光阵列的架构原因。$JBL的1.6T LRO还利用Sivers激光器建立了最具戏剧性的护城河之一，他们的炉边谈话中引用了这一点。 如果你认为CW激光器可以和Sumitomo/Furukawa及其他厂商的可互换，可以即插即用……我无话可说。 再次强调：$SIVE为领先的CPO玩家制造架构独特的CW激光器。 3. 我不确定需要说多少次： $SIVE在2024-2025年一直在走开发合同路线。人们使用TTM收入或以前的市销率指标是完全错误的指标，因为2027年才有量产爬坡。 这和$AAOI在2027年上半年量产爬坡一样。 $AEHR在资质认证后量产爬坡。 $LPK在资质认证后量产爬坡。 这只是半导体行业缺少资质认证周期以及对当前财务建模的问题。 至于$LITE的比较（也是我去年长期持有的）： $LITE最初确实是销售激光裸片，然后才收购Cloud Lite和其他下游光学引擎组件。 这就是$SIVE今天的处境——从CPO的激光咽喉要道起步： 人们正基于非常孤立的TAM预测来建模激光收入。与此同时Sivers正在通过并购来扩展TAM预测的收入。 这不是简单的台湾公司组件FAU+爬坡估值建模。 既然激光公司如$LITE、$COHR以向下游扩张使激光更有价值而闻名，然后事后垂直整合（晶圆厂、封装）。 同样，Sivers在这些公司成为十亿美元公司之前就与他们合作过。我有高度信心知道他们知道该收购什么来扩展ELS/光引擎堆叠+可插拔收发器的TAM。 只是很烦人，总有人不理解这些细微差别却对我的长仓指手画脚，说些错误的东西。 我遇到同样的情况说「$AXTI不是瓶颈！InP不需要！中国！」，当时股价是14美元。 现在是140美元。 我遇到同样的情况说「$AAOI要跌50%！」，当时是65美元。或者「AOI管理层有问题」，当时是30美元。 现在是170美元。 我遇到「$SOI没什么新东西」，当时是45美元。 现在是170美元。 我认为我是少数真正理解光子学细微差别的人之一，因为我确实预判了$LITE、$TSEM、Innolight、$AXTI、$AAOI、$SOI，这些在过去一年里表现超过光子学市场和整体市场。 现在我做多$SIVE。
英文原文
Photonics is nuanced and using ChatGPT/Gemini makes you miss all of it: 1. $SIVE is actually a chokepoint and partially a bottleneck. The reason it's a chokepoint is leading CPO/optical hyperscaler players go through Sivers, likely: Ayar. Celestial. Lightmatter. Lightelligence. Poet. If you take out Sivers, you literally can't make some of their products + delay their roadmap by years. As many are sole/primary source but are heading the direction on multi-source. As for the bottleneck argument: Win Semi is the bottleneck for scaling laser production. But... the nuance is when you have capacity allocated for the next few years. You become part of the bottleneck itself if players fight you for allocation of finished lasers. That's the nuance people miss with capacity allocation dynamics. It's like saying $SNDK is not part of the NAND bottleneck when Kioxia makes all of it. But when Sandisk has the ultimate control of output supply, they become the bottleneck + have all the pricing power. Sivers controls output supply of CW lasers given allocations, and as seen with $LITE earnings, CW laser is currently bottlenecked as everyone seems to be stuck producing EMLs. 2. Like how LLMs always uses em-dashes. You can tell when people use AI when they always use the same "CW is a dumb interchangeable laser" argument or compare "power" specs after conflating different architectures. That's why your "analysts" using AI will get this wrong over and over. There's CW lasers... and then there's a specific architectural design that Sivers achieves with DFB lasers. If you compare power specs with $LITE vs. Sivers, Lumentum wins in isolation. But they're completely different laser architectures. All the leading CPO players like Ayar, chose $SIVE for an architectural reason for high power, low thermal, laser arrays. $JBL 1.6T LRO also made one of the most dramatic moats cited by their fireside chat, using Sivers lasers. If you think CW lasers are interchangeable with Sumitomo/Furukawa, and others. And can be plug-and-play... i don't know what to tell you? Again: $SIVE makes architecturally unique CW lasers for leading CPO players. 3. I'm not sure how many times I need to say this: $SIVE for 2024-2025 has been going through development contracts. People using TTM revenue or former P/S metrics are using completely the wrong metrics, when there's volume ramp in 2027. It's the same with $AAOI which volume ramps in H1 2027. $AEHR which volume ramps after qualification. $LPK that volume ramps after qualification. This is just missing qualification cycles in semiconductors and how to model financials currently. As for the $LITE comparisons (which was also my long last year): $LITE literally started off selling laser dies before acquisition of Cloud Lite and other downstream optical engine components. This is where $SIVE is at today with starting off in the laser chokepoint for CPO: People are modeling laser revenue off very isolated TAM projections. Meanwhile Sivers is targeting M&A to expand revenue for TAM projections. This is not a simple component FAU + ramp valuation modeling over with a Taiwanese company. Since Laser companies like $LITE, $COHR are known to downstream expand to make their lasers more valuable, then vertically integrate (fabs, assembly) afterward. Again, Sivers worked with Ayar and these types of companies before they all became billion dollar companies. I have high conviction knowing they know what to acquire down the ELS/optical engine stack + pluggable transceiver for TAM expansion. It's just annoying when I get people who don't understand the nuances backseat commenting wrong things about my longs. I got the same thing about $AXTI is not a bottleneck! InP isn't needed! China! back at $14. Now it's $140 I got the same thing about $AAOI "is going down 50%!" back at $65. or "AOI management is shady at $30". Now it's $170 I got the "there's nothing new with $SOI" back at $45. Now it's $170. I think I'm one of the few who actually understands the nuances with photonics, since I did call out $LITE, $TSEM, Innolight, $AXTI, $AAOI, $SOI, that outperformed both photonics markets and overall markets over the past year. And now I'm long on $SIVE.
-
JPM炉边会显示JBL 1.6T LRO量产早于预期，SIVE激光架构形成护城河且需求近乎无上限。
$SIVE 与 $JBL 的 1.6T 光收发器量产： 根据 JPMorgan 炉边谈话，现在比预期更早。 他们宣布的内容： > $SIVE 激光架构暗示“相当显著的护城河”。 > 其 1.6T 存在极端需求，此前市场并不知道具体量级。 > 时间线快于预期，将收入实现窗口提前。 声明内容： 1. Jabil 的 1.6T LRO “将在未来1到4个月进入不同认证”。 “认证可能需要2到6个月。” 考虑到现在是2026年上半年5月，量产和收入实现可能在3到10个月内开始。 以6.5个月中点看，就是2026年底。 很多此前估计是2027年下半年。 3. 架构上，它“比当前1.6T 功耗曲线低约11千瓦”。 超大云厂商会喜欢听到这个，而这就是通过 $SIVE 作为关键光子学 chokepoint 证明的竞争差异化和相当显著护城河。 4. “在这一点上，不是份额问题。真正的问题是跟上整个市场的自然增长。” 这再次显示巨大需求已经超过供应。 含义是，关键变成 Sivers + Jabil 能一起生产多少，因为它们生产的任何东西都会被买走。 这种表述对 Sivers 相对于当前市值的收入极其重要。 市场此前不确定 Sivers x Jabil 的确切需求量和商业时间线。 Jabil 刚刚公开确认，使用 $SIVE 激光的 1.6T LRO 需求本质上没有上限。
英文原文
$SIVE mass production for 1.6T optical transceivers with $JBL: Is now earlier than expected per JP Morgan Fireside chat. Here's what they announced: > "Relatively dramatic moat" implied with $SIVE laser architectures > Extreme demand for their 1.6T, which was previously unknown in terms of volume. > Faster than expected timelines, pulling revenue realization window forward. The statement: 1. Jabil’s 1.6T LRO: "Goes into different qualifications across the next 1 to 4 months" “The quals can take anywhere between 2 to 6 months" Given its May H1 2026, mass production and revenue realization could begin in anywhere between 3 months to 10 months. So late 2026 with 6.5 month midpoint. Lot of former estimates were H2 2027. 3. Architecturally it's "which is about 11 kilowatts dramatically lower than current 1.6T power profiles" Hyperscalers would like to hear this, and this is the competitive differentiation + relatively dramatic moat proven with $SIVE as the critical photonics chokepoint. 4. "At this point, it's not about share. It's really about keeping up with the organic growth of the entire market." Again this shows that the enormous demand has outstripped supply. The implications are that it’s more of a matter of how much Sivers + Jabil can build together, as anything they make would be bought. This type of statement is just incredibly material for Sivers revenue relative to their current marketcap. The market was previously uncertain about the exact volume demand and commercial timeline from Sivers X Jabil. Jabil just publicly confirmed that the demand for their 1.6T LRO with $SIVE lasers is essentially uncapped.
-
建议美日将Ulvac列入出口管制，以打击中国人形机器人稀土磁体设备瓶颈。
一个随手想法： 美国政府/日本应该把 Ulvac（6728）列入出口管制名单，让它们停止向中国发货。 这样就能扰乱中国整个人形机器人计划（因为它是“军民两用应用”）。 作为对上游 InP/稀土相关出口管制的报复。 对袜子出口加45%关税没什么用，但扰乱中国机器人计划，确实有用。 Ulvac 是日本在钕磁体上的主要 chokepoint。 “Ulvac 长期通过其中国子公司制造稀土磁体真空熔炼炉。” 所以也许该让这件事停下来？ 如果它们停止出货，你可以打断宇树和其他中国人形机器人量产供应链。 只有当中国允许稀土出口重新流动时，出口才能继续。
英文原文
Just a shower thought: US Gov/Japan should put Ulvac (6728) on the export control list so they stop shipping to China. That way you can disrupt China's entire humanoid program (since it's "Dual Use Military Applications"). As retaliation over upstream InP/rare earth related export controls. Adding 45% tariffs on sock exports won't do much, but disrupting China's robotics program, sure. Ulvac is Japan's major chokepoint over neodymium magnets. "Ulvac has long manufactured rare-earth magnet vacuum melting furnaces through its Chinese subsidiary". So maybe put that to rest? If they stop shipping, you can break Unitree's and other humanoid mass production supply chains in China. And only if they allow rare earth exports to start flowing again, then exports can continue.
-
SIVE纳入MSCI并获得660万美元CHIPS资金，政府托底关键瓶颈。
$SIVE 刚被纳入 MSCI，这意味着两周内可能又有数千万美元买盘压力。 此外还有新的660万美元 CHIPS Act 资金进入，这是很棒的资本注入。 最大的是这项 CHIPS Act 进展带来的收入含义，无论它们正在做什么黑魔法。政府把 Sivers 作为关键 chokepoint 托底，是锦上添花。 我个人认为它还会涨很多。
英文原文
$SIVE just got MSCI inclusion and that's another likely tens of millions buying pressure in 2 weeks. Then there's new $6.6M CHIPS ACT funding coming in, which is an amazing capital injection. The largest thing is revenue implications from this CHIPS ACT development, whatever black magic they're working on. Gov backstopping Sivers as a critical chokepoint is a cherry on top. I personally think it's going much higher.
-
SIVE获得美国CHIPS Act 660万美元，与BAE合作用于美国防务基础设施现代化。
最新：$SIVE 获得美国 CHIPS Act 660万美元。 这是第二年项目的660万美元。 与 BAE Systems 合作：“使用 Sivers 技术现代化美国防务基础设施”。 像 $SIVE 这样小的公司获得 CHIPS Act 资金，极其看多。 因为它把 Sivers 定位为一个关键、由美国政府托底的国家安全 chokepoint。
英文原文
Just in: $SIVE gets $6.6M from the US CHIPS ACT. This is a $6.6M Year 2 Program. In collaboration with BAE Systems: "Modernizing U.S. Defense Infrastructure Using Sivers Technology" This is incredibly bullish to have such a small company in $SIVE to get CHIPS ACT funding. As it positions Sivers as a critical, US-government backstopped chokepoint for national security.
-
深度分析光子学供应链四只股票，强调TAM扩张和垂直整合逻辑，认为是长期核心持仓而非短期交易
当我看到像这样（而且很多）的来自散户投资者的评论时，我立刻认为他们缺乏技术深度。 我来逐一分析从$SIVE到$LPK的每家公司： 1. 光子学TAM（总可寻址市场）从$140亿增长到$1540亿，仅仅两年时间，而且它很可能会在2030年之后继续增长，因为它是下一代架构的首选。 它不会在1年内消失。它不会在3年内消失，这就是为什么$LITE的溢价越来越高，因为他们已经排产到2028年了。 $SIVE供应CW（连续波）激光器，高度绑定CPO（共封装光学）和现在的可插拔收发器，用于1.6T和3.2T... 适用于像$JBL、Ayar、Lightmatter、Lightelligence、$POET、$MRVL、Celestial和$AMD这样的预期公司。 这不是一个"交易"，它是下一代光子学的核心瓶颈和IP持有者。 而且作为未来几年的舒适持仓是很合适的，因为他们正在扩展成为下一个$LITE。 我个人看到的风险（既然他们已经与这么多玩家完成认证），主要是他们能从整体光学超级周期中捕获多少TAM（市场空间）。（以及Win Semi产能爬坡的潜在风险，但Win体量很大所以我可以放心睡觉）。 因为仅仅供应激光器不足以支撑估值。 是TAM向下扩展到制造整个ELS（外部激光源）或整个可插拔收发器，才让这些激光器公司如此有价值。 之后，他们可以向上垂直整合以扩大毛利率，像$COHR那样做激光代工甚至衬底级别的业务。 在我看来，这是非常不对称的风险/回报比，因为我们已经在$LITE身上看到过——他们从$20亿增长到$800亿。 2. $LPK——是下一代先进封装转向玻璃基板的最纯粹敞口，没有SKC Absolics混乱的财务问题。 几乎每家主要半导体公司从$INTC到三星都在采用玻璃基板。 $LPK基本上就是该瓶颈的$ASML，因为他们目前供应给全球约80%的玩家。 是的，设备供应商有"贸易周期"，比如$ASML，如果有更多晶圆厂资本支出，ASML就会增长。但如果出现低迷，这些往往表现不佳，也无法捕获之后发生的所有量产出货。 然而，如果市值是$6.5亿，他们正在实现$1-2亿收入，随着每个客户的量产出货增长，他们从玻璃基板周期中获得的收益可能会超过当前估值。 而且他们会有基本面支撑（因为越来越多的公司采用封装转型），这会维持他们的估值。 现在只是等待产能爬坡的时机而已。 3. $AAOI——这简直就是美国版的光子学$INTC。可以说Intel不是长期投资。 猜猜你们所有的光收发器是在哪里制造的？ 中国、泰国、马来西亚。如果你看看Innolight、Eoptolink、$FN和其他公司。 AOI正在建设最大的美国本土供应链，包括CW激光器代工以及800G、1.6T组装。 是的，这也有可插拔周期起伏。明年会有1.6T的浪潮，然后CPO会蚕食可插拔市场。 但由于他们在内部制造整个供应链，他们对其他细分市场有极大的选择性。而且像$NVDA的老一代GPU一样，会有主权数据中心对老一代可插拔收发器的需求，来自像$AAOI这样的厂商。 它很可能会继续上涨，因为它在2026年下半年达到每月$4亿+收入的目标。 一路上有很多不同的短期波动，比如$6亿的稀释。 4. $IQE——？？？这是西方世界最重要的外延晶圆玩家之一。 $MTSI不遗余力地偿还了IQE的债务，因为他们不能让IQE倒闭。$IQE还向$LITE供货。 目前世界在 Landmark评论提到的外延晶圆水平和InP衬底水平都存在瓶颈。 他们的财务数据虽然糟糕，但从原始账面价值和他们在整个西方供应链中的价值来看……完全支撑他们的估值。其他光学公司不会让他们核心的上游供应链倒闭。 因为这些价值数千万美元的材料出问题，会搞砸下游价值数十亿美元的产品。 再次强调，光子学是扩展AI所需的下一代架构。不是量子计算那种"还在开发中"的东西。 它就在这里，而且是$NVDA选择的架构。 如果几年后这些都涨了很多，我一点也不会惊讶。 那些认为"只是因为我提到了"就在3个月内一波流的 people，根本不知道他们在说什么。 机构最终会买入这些标的（就像Point 72买入$IQE那样），散户只会在估值已经涨了600%之后才知道。 真的应该在发表评论前做好研究： 这些都是需要深入供应链知识的前瞻性增长公司。
英文原文
When I see comments like this (and there are a lot) from retail investors: I immediately think they lack the technical depth. I'll walk through each one from $SIVE to $LPK: 1. Photonics TAM goes from $14B -> $154B In just two years time, and it's likely going to keep scaling past 2030 as it's the next generation architecture of choice. It's not going away in 1 year. It's not going away in 3 years, which is why $LITE premiums keep going higher since they're backlogged into 2028. $SIVE supplies CW lasers and is highly tethered to CPO and now pluggable transcivers for 1.6T and 3.2... For expected companies like $JBL, Ayar, Lightmatter, Lightelligence, $POET, $MRVL Celestial, and $AMD. This isn't a "trade", it's the core chokepoint and IP holder for the next generation of photonics. And it's a comfortable hold for the next few years as they scale to become the next $LITE. The risk I personally see (since they're already qualified with so many players), it's mainly how much TAM they can capture of the overall optical supercycle. (And potential risks with Win Semi volume ramp, but Win is massive so I can sleep tightly there). As just supplying lasers isn't enough to justify valuation. It's TAM expansion downward into making the entire ELS or entire pluggable transceiver that makes these laser companies so valuable. Then afterward, they can vertically integrating upward for gross margin expansion upward like $COHR into doing the laser fabs or even substrate level. And that in my view is a very asymmetric risk/reward ratio as we've already seen this done with $LITE as they went from $2B to $80B. 2. $LPK - Is the purest exposure, without the messy financials of SKC Absolics, as the next advanced packaging shift for glass substrates. Almost every single major semi company from $INTC to Samsung are adopting glass substrates. $LPK is basically $ASML of this chokepoint, since they supply to ~80% of the global players currently. Yes, there's "trade cycles" for equipment suppliers like $ASML, where if there's more foundry capex, ASML scales up. But if there's downturns, these tend to perform poorly, and don't capture all the volume ramp that happens after. However, if the MC is $650m and they're making $100-200M, revenue per costumer volume ramped, the amount they make from the glass substrate cycle will likely exceed current valuations. And they'll have baseline fundamentals (as more companies adopt the packaging shift), that keeps their valuation up. It's just a waiting game for volume ramp at this point. 3. $AAOI - This is literally $INTC but for America + Photonics. It's like saying Intel is not a long term investment. Guess where all your optical transcivers are made? China. Thailand. Malaysia. If you look at Innolight, Eoptolink, $FN, and others. AOI is building the largest Made in America supply chains for both CW laser fab, as well as 800g, 1.6T assembly. Yes, there are pluggable cycle ups and downs to this as well. There's going to be a wave for 1.6T next year, then CPO cannibalizes pluggables down the road. But since they make the entire supply chain in house, they have extreme optionality for other segments. And like $NVDA older gen-GPUs, there's going to be sovereign DC requirements for older gen pluggables from names like $AAOI. It's likely going to keep rising as it hits that $400m+/month revenue target H2 2026. There's just a lot of different short term volatility along the way like the $600m dilution. 4. $IQE - ??? It's one of the most important players in the Western word for epiwafers. $MTSI went out of their way to pay off IQE's debt because they can't have them going under. $IQE is also supplying to $LITE. The world is currently bottlenecked both on the epiwafer level from Landmark comments and InP substrate levels. Their financials were track but the raw book value, and value they hold to the entire Western supply chain... completely justifies their valuation. And other optical companies will not let their core upstream supply chain go under. As these tens of millions worth of materials would screw up tens of billions worth of downstream products. Again photonics is the next generation architecture required to scale AI. It's not Quantum where it's just "In development". It's literally here and the architecture of choice by $NVDA. I would not be surprised if all of these are a lot higher in 3-4 years time. People who think it's one and done in 3 months time "only because I mentioned it" don't know what they're talking about. Institutions would have bought up the name eventually (like Point 72 on $IQE) and retail would only find out after their valuations are 600% higher. Should really do the research before adding comments like these: These are all forward growth companies that require in-depth supply chain knowledge.
-
把 POET 的大单和 SIVE 的激光瓶颈联系起来
如果你还不知道，$POET 因为 Lumilens 的一笔 5000 万美元采购，盘前涨了 22%。 后续还会按更长期框架扩到 5 亿美元。 正如 Sivers 2025 年报里提到的：$POET 会在 2026 年下半年和 $SIVE 一起放量。 这些中游玩家往上反向拉动 $SIVE 的需求，而激光就是一切的 chokepoint。 所以，是的，这对 Sivers 极度利好。
英文原文
If you didn't know $POET is up 22% premarket on a $50m purchase from Lumilens. Scaling to $500m with a longer term framework. As mentioned in Sivers 2025 annual report: $POET is ramping up H2 2026 with $SIVE. Any demand from these midstream players back to $SIVE as the laser chokepoint for everything. So yes, this is highly bullish for Sivers.
-
用历史市值路径说明 laser chokepoint 的威力
回答这个问题，我就拿一些 laser chokepoint 的历史数据出来： $LITE 从 30 亿 -> 150 亿 -> 800 亿美元，只用了从 2024 年开始的 2 年。 $AAOI 从 7.7 亿 -> 150 亿美元，只用了 2025 年开始的 1 年。 $SIVE 现在在 2026 年是 16 亿美元。 世界上这类公司没多少，而 laser 又是 photonics 的绝对中心。 每家公司都拥有一个特定的 chokepoint，对应一次光学架构的变化。 $LITE 对应 EML。 $AAOI 对应 cw 800g/1.6T pluggable。 而现在 $SIVE 对应 cw CPO。
英文原文
To answer that question. I’ll just float some historical data out there with laser chokepoints: $LITE went from $3B -> $15B -> $80B in 2 years from 2024. $AAOI went from $770M -> $15B in 1 year from 2025. $SIVE is $1.6B today in 2026. There’s not many in the world and lasers are the absolute center of photonics. Each owned a specific chokepoint from optical architectural shifts. $LITE for EML. $AAOI for cw 800g/1.6T pluggable and now $SIVE for cw CPO.
-
用历史说明 SIVE 已站在新的 laser chokepoint 上
$LITE 用 2 年从 20 亿涨到 800 亿，因为它掌握了 EML 的 laser chokepoint。 $AAOI 用 1 年从 14 亿涨到 140 亿，因为它掌握了 800g / 1.6T transceivers 和组装的 laser chokepoint。 $SIVE 今天大概是 14 亿美元，在 CPO 之前就已经掌握了 CW laser chokepoint。 Sivers 是我最喜欢的一个。
英文原文
$LITE went from $2B to $80B in two years by owning the laser chokepoint for EML $AAOI went from $1.4B to $14B in one year by owning laser chokepoint for 800g/1.6T transceivers + assembly $SIVE is $1.4B today before CPO and owns the CW laser chokepoint. Sivers is my favorite out of everything.
-
分析Sivers作为CPO激光供应商的市场地位及垂直整合潜力。
我并没有说Sivers现在就应该被估值到100亿美元以上。 我说的是，如果Sivers在美股市场上市，我预期它的估值会在30亿美元左右。明年可能达到100亿美元以上。 因为他们很可能是$SIVE（$JBL、$MRVL、AMD、Ayar、els、Lightmatter、$POET等公司）的激光供应商，用于CPO或1.6T光收发器。 而且我高度确信他们正在与$AAPL合作开发用于消费类设备的硅光子(SiPH)技术。 根据高盛报告，CPO整体TAM（可寻址市场）在未来两年将从零增长到910亿美元。 Sivers向各大厂商供货，并从$LITE因受$NVDA产能分配限制以及2027年产量爬坡影响而停滞的溢出需求中获益。 然后他们只需要复制$LITE和$COHR的做法，通过收购封装IP或更多光引擎IP，向下游垂直整合完整的ELS（外接激光源）。 但首先他们得掌握激光这个瓶颈环节——而他们现在已经在做了。
英文原文
I didn’t say it should be valued at $10B+ today. I said I expected $SIVE to be around ~$3B if they were listed on US markets. And could be $10B+ next year Since they likely are the laser supplier to $JBL, $MRVL, $AMD, Ayar, onet(els), Lightmatter, $POET and many others for CPO or 1.6T optical transceivers. And high confidence work with $AAPL on SiPH for their consumer devices. CPO overall tam goes from 0 to $91B in the next two years from GS report. Sivers supplies to major players, and captures overflow from $LITE getting stalled out by capacity allocations from $NVDA and volume ramps over 2027. Then they just need to pull a $LITE $COHR then vertically integrate IP downstream by doing the full ELS by buying packaging IP or more optical engine IP. But that starts off by owning the laser chokepoint which they do now
-
给出 SIVE 未来市值路径与对标 LITE 的想法
我觉得 $SIVE 明年会到 100 亿美元以上，到了 2028 年如果管理层把牌打好，能扩到 400 亿美元以上。 这很大程度上取决于管理层是不是足够有野心，想不想成为下一个 $LITE。 但这正是 Lumentum 当年怎么做的：先拥有 laser chokepoint，再向下游买 IP，把更多 TAM 吃进去。
英文原文
I think $SIVE ends up $10B+ next year and can scale to $40B+ in 2028 if they play their cards right. Really depends on how ambitious management is if they want to become the next $LITE. But this is exactly how Lumentum started owning the laser chokepoint then IP acquisition downstream to capture more TAM.
-
说瑞典媒体可能终于发现股权已转向美国机构
我在想，瑞典媒体是不是终于意识到他们都干了什么，于是停止发帖了？ $SIVE 是我见过最有吸引力的 CPO 多头，尤其是在 laser chokepoint 这块。 https://t.co/f1zGx9Bli1
英文原文
I wonder if Swedish media realized what they’ve done transferring control over to American investors/institutions and stopped posting? $SIVE is the most compelling CPO long I’ve seen, especially for the laser chokepoint. https://t.co/f1zGx9Bli1
-
再次验证 AXTI 的 InP substrate 瓶颈判断
还记得我去年对 $AXTI 的 InP substrate 瓶颈判断吗，anon？ IntelliEPI CEO（2026Q1 财报）： “Indium phosphide substrate shortage is a bottleneck for the entire AI infrastructure.” Digitimes：Taiwan’s IntelliEPI warns of severe indium phosphide supply shortage 我当时就说，随着 photonics 放量，下一代 AI 架构全面转向光学后，InP 会出现重大瓶颈。 这是我关于 AXT 这个上游 chokepoint 最准确的一次判断。 我通常会比市场早几个月，但方向上经常会兑现。 当我已经在这些瓶颈里赚了 1800%+ 的时候，我现在又在做多 CPO，押下一个大超级周期。
英文原文
Did you remember my $AXTI InP substrate bottleneck call last year anon? IntelliEPI CEO (Q1 2026 ER): "The InP substrate shortage is a bottleneck for the entire AI infrastructure" Digitimes: "Taiwan's IntelliEPI warns of severe indium phosphide supply shortage" I said as photonics ramps: There was going to be a major InP bottleneck as all the next-gen AI architectures go optical. This was most goated call with AXT as the upstream chokepoint. I'm usually a few months ahead of time, but they play out directionally. While I'm sitting in existing bottlenecks up 1800%+, I'm long CPO as the next major supercycle.